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Abstract
The gain, loss, and modification of gene regulatory elements may underlie a significant proportion
of phenotypic changes on animal lineages. To investigate the gain of regulatory elements
throughout vertebrate evolution we identified genome-wide sets of putative regulatory regions for
five vertebrates, including human. These putative regulatory regions are conserved non-exonic
elements (CNEEs), which are evolutionarily conserved yet do not overlap any, coding or
noncoding, mature transcript. We then inferred the branch on which each CNEE came under
selective constraint. This analysis identified three extended periods in the evolution of gene
regulatory elements. Early vertebrate evolution was characterized by regulatory gains near
transcription factors and developmental genes, but this trend was replaced by innovations near
extra-cellular signaling genes, and then innovations near post-translational protein modifiers.
The gain, loss, and modification of gene regulatory elements has led to many phenotypic
changes during animal evolution, including pigmentation changes in dogs, fish, and flies (1–
3), bristle patterns on flies (4), and skeletal differences in fish (5, 6). A recent analysis of
published genome-wide association studies also noted a strong enrichment for regulatory
regions to be in linkage with trait/disease associated single nucleotide polymorphisms (7).
Mutations in regulatory modules can avoid the pleiotropic effects that often result from
protein-coding mutations, and hence provide an exceptionally flexible source of
evolutionary change (8).
Computational methods can identify strong candidates for gene regulatory elements by
detecting regions of the genome that show evolutionary conservation, yet do not appear in
any coding or noncoding mature transcript. While many noncoding RNAs, or noncoding
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portions of protein-coding transcripts, may serve a regulatory purpose, we exclude these
regions to focus on cis-regulatory elements that are functional at the DNA level. For this
reason we use conserved non-exonic elements (CNEEs) to describe the set of putative
regulatory regions. Strong conservation indicates a sustained purifying selection against
mutations, suggesting the genomic region confers selective advantage and hence is
functional. This procedure is independent of the tissue-type, developmental stage or
environmental circumstance in which these elements become relevant. An experimental
survey of CNEEs found that 50% of the 437 CNEEs tested in an in vivo mouse enhancer
assay drove reproducible expression patterns during mouse development (9). Since only a
single time-point during development was tested, many of the CNEEs that did not drive
expression in the assay may act as transcriptional enhancers at other developmental stages.
CNEEs have also been shown to act as repressors and insulators (10–12).
Early genome-wide studies of CNEEs not only noted their role in regulating the
transcription of nearby genes, but also observed that CNEEs tend to be located near genes
acting as developmental regulators, including many transcription factors, to finely control
vertebrate development (13–16). Only a handful of vertebrate CNEEs date back to our
chordate ancestor (17), suggesting that the vast majority of regulatory elements in the
genomes of living vertebrates have arisen since their common ancestor 650 million years
ago.
To better understand this gain of regulatory sequence on vertebrate lineages we identified
genome-wide sets of CNEEs for the human genome as well as mouse, cow, medaka, and
stickleback. Mouse and cow have well-assembled and annotated genomes that can leverage
the densely sampled clade of placental mammals to identify and date CNEEs in their
genomes. Ray-finned fish are the other clade of vertebrates with enough well-assembled
genomes to identify and date CNEEs. Because the ray-finned fish diverged from placental
mammals ~425 Mya their lineage offers a largely independent analysis of regulatory trends
in vertebrate evolution.
Using multiple alignments of vertebrate genomes, a phylogenetic hidden Markov model was
employed to determine CNEEs (18). For each CNEE we used genomic proximity to predict
the gene being regulated. We assigned each CNEE to the gene with the closest transcription
start site (18). We then inferred the evolutionary branch on which each CNEE came under
selective constraint. To do this, for each CNEE we determined the most recent common
ancestor of all species in the vertebrate-wide multiple-alignment that have an orthologous
piece of DNA aligning to at least one-third of the CNEE (Fig. S1). For more than 99.97% of
CNEEs we use this most recent common ancestor as the time of origin. In less than 1000
rare cases there is evidence that a significant onset of constraint occurred following the most
recent common ancestor of all species in the alignment (19). In these rare cases we use the
branch showing the onset of constraint as the origin of the CNEE (Fig. S1). The onset of
constraint must be more significant than the rejection of the neutral model by the alignment
as a whole (18). Finally, we examined the functional classes of genes that acquired the most
regulatory innovations during each evolutionary epoch since the common ancestor of living
vertebrates.
For our study of epoch-specific selection in the human lineage, we created alignments of 40
vertebrate genomes (including 31 mammals, 2 birds, 1 lizard, 1 amphibian, and 5 fish)
projected onto the human genome (18). From this alignment we found 2,964,909 human
CNEEs, averaging 28 bases in length and covering 2.9% of the genome.
To ensure that the CNEEs are enriched for regions that have been under selection, we
examined the derived allele frequency spectrum of segregating single nucleotide
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polymorphisms found by the HapMap Consortium (20) in the Yoruban population (18). The
frequency of derived alleles in the Yoruban population is shifted toward lower frequencies
in the set of CNEEs compared to intronic regions (p<10−90) as is characteristic of sites under
purifying selection, where the majority of mutations are deleterious and rarely progress to
higher frequencies. Although the shift in derived allele frequencies for the set of CNEEs is
not as strong as that for non-synonymous changes in coding regions, these results
demonstrate that this set is strongly enriched for regions evolving under purifying selection
in humans (Fig. S2).
Experimental methods such as ChIP-seq (21) and DNAse hypersensitivity (22), while still
limited by the tissue-type and time point of the experiment, offer an alternative to in vivo
mouse models, that allows the regulatory potential of CNEEs to be assessed on a much
larger scale. We examined the overlap of the CNEEs with over 100,000 DNase
hypersensitivity sites identified in human CD4+ cells, indicating regions of open chromatin
(23). There is a 1.7-fold enrichment in these DNase hypersensitivity sites compared to a
random control for overlap with the set of CNEEs (p<10−800) (18). More specific to being a
regulatory region, although restricted to a single protein of interest, are locations of protein-
DNA interactions discovered by ChIP-seq. We examined the intersection of CNEEs with
ChIP-seq datasets for the factors SRF, GABP, and NRSF in human Jurkat cells (24). There
is a 2.5-fold enrichment for SRF binding sites (p<10−142), a 3.5-fold enrichment for GABP
binding sites (p<10−210), and a 4.7-fold enrichment for NRSF binding sites (p<10−220). This
indicates that our set of CNEEs is strongly enriched for functional elements. Our set of
CNEEs typically covers only 1 out of every 10 putative regulatory elements identified by
these experimental approaches. However, evolutionary conservation will only detect those
binding sites under considerable purifying selection in multiple species and not lineage-
specific or recently created regulatory elements.
To assess the functions of genes putatively regulated by the CNEEs, we assigned each
CNEE to the gene with the closest transcription start site and determined the Gene Ontology
(GO) (25) terms associated with that gene. We tested for enrichment against the assumption
that CNEEs are uniformly distributed throughout the genome, allowing for differences in
genic and intergenic sizes among classes of genes (18).
While the set of human CNEEs, when treated as a whole, is enriched in locations where the
closest transcription start site is a “trans-dev” gene (“transcription factor activity”
p<10−2000, “development” p<10−3000), these results showed that this enrichment is due to
the subset of human CNEEs that came under selection prior to the boreoeutherian (human-
cow) ancestor (Figs. 1 and S3 and Tables S1 and S2). Despite a dramatic enrichment for
regulatory innovations near trans-dev genes in the earliest period of vertebrate evolution
through the radiation of tetrapods onto land and to a lesser extent in our early mammalian
ancestors, we found a sharp decrease from that enrichment to a rate expected by chance, or
less, since the ancestor of placental mammals, approximately 100 Mya.
Separating developmental genes and transcription factors shows that developmental genes
maintained a moderate enrichment for new regulatory elements until a sharp decline in our
early placental ancestor. Transcription factors were dramatically enriched for regulatory
elements in our early vertebrate ancestor, but this enrichment has consistently declined until
reaching random expectation in our placental ancestor (Figs. 1 and S4).
We repeated the above study using the mouse, cow, medaka and stickleback species as
reference species, each time starting with a new multiple alignment of other vertebrates to
the chosen reference species. The analysis of each of these additional lineages gave similar
results (Fig. 1).
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Creating genome-wide alignments for vertebrate species is still an active area of research.
We used alignments to infer the branch on which CNEEs came under selection, so
inaccuracies in the alignment may result in inaccurate inferences as to when some CNEEs
came under selection. False positive alignments to distantly related species may cause
CNEEs to appear more ancient. False negatives in the alignment process, combined with
CNEEs missing from assemblies due to low-coverage sequencing or deletions, may cause
CNEEs to appear more recent. However, to explain the trends described there would need to
be a systematic bias that treated the CNEEs associated with genes of one function differently
than those associated with genes of other functions.
These findings are not due to biases in length, rate of evolution, or rate of turn-over between
CNEEs near various functional classes of genes. We have greater statistical power to align
both longer and slower evolving CNEEs over large evolutionary distances. We also have
greater power to detect evolutionary conservation in longer and slower evolving CNEEs.
Both of these factors contribute to our sets of very ancient and very recent CNEEs being
enriched for longer and more slowly evolving elements. However, there is not a consistent
trend for CNEEs associated with trans-dev genes or genes with any particular GO term to
have different lengths or rates of evolution (Figs. S5 and S6). For this reason it is unlikely
that our results are caused by either of these biases in creating alignments and detecting
conservation. To show the results are not due to different rates of turn-over for CNEEs near
trans-dev genes, we identified CNEEs in the human, mouse, and cow referenced alignments
that have clear orthologs in other well-assembled mammalian genomes, but are not present
in either the human and rhesus, mouse and rat, or dog and horse genome assemblies (18).
These CNEEs are likely to have been lost in one of the mammalian lineages after having
been present in the ancestor. We counted the number of these lost CNEEs near trans-dev
genes versus other types of genes and found no consistent difference (Fig. S7). This
indicates the results are unlikely to be the result of different rates of turn-over.
Neither are the results due to a bias in dating CNEEs whose time of origin is uncertain. The
same trends seen in the entire set of CNEEs are present in the subset that have a clear point
of origin, i.e. that exist precisely in all species descendant from a common ancestor, and in
no additional species (Fig. S8).
To ensure that the changes we see in enrichments over time are robust against the alignment
methods and against choices in what species are included in the analysis we have performed
our analysis on a separate human-referenced alignment using only deeply-sequenced and
well-assembled genomes along with stringent alignment parameters (Fig. S9). The results
were similar. To ensure that our results are robust against the choice of gene set, CNEE to
gene assignment algorithm, and GO term to gene mapping, we performed our enrichment
analysis for the human lineage using a completely independent method (26) (Fig. S9). Again
the results were similar. Hence, our conclusions are robust to a large number of variations in
methodological approach.
Given the changes observed for trans-dev genes, we extended our analysis to each of the
~13,000 GO terms found in vertebrate genomes. We determined the approximate times of
all regulatory innovations associated with each GO term and ranked all terms by their
increase or decline over time, based on the slope of a linear model fit to time-vs-percent of
CNEEs associated with the GO term. At one end of the spectrum, the top forty fastest-
declining gene categories were “development,” “transcription factor activity,” and related
GO terms, irrespective of the choice of human, mouse, cow, medaka, or stickleback as the
reference genome (Tables S3 – S7).
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At the other end of the spectrum, we found increases in the accumulation of regulatory
innovations for several GO terms, suggesting that the decrease in regulatory innovations
near trans-dev genes has been accompanied by an increase in innovations near genes of
other functions. These include genes annotated with “post-translational protein
modification,” “organelle membrane,” and other GO categories related to intra-cellular
signaling (p<10−110, given the dating of CNEEs and the annotation of genes) (Tables S8 –
S10).
This set of GO terms does not show a significant enrichment in the medaka or stickleback
lineages; however, the fish lineages do not have the dense tree of closely related species that
is required to identify recent regulatory innovations. Instead, the terms showing the sharpest
increases on both fish lineages are “receptor binding,” “plasma membrane,” “signaling,” and
other related terms (Tables S11 – S12). Upon analyzing inter-cellular membrane signaling
genes in the mammalian lineages we found that mammalian ancestors too once had a high
rate of regulatory innovations near this same set of genes, but such innovations have now
returned to random expectation (Fig. 1). In fact, “receptor binding” genes show a peak of
regulatory innovation between the time of our amniote ancestor and our placental
mammalian ancestor, relative to the rate of innovation before and after this time period
(p<10−250, given the dating of CNEEs and the annotation of genes).
For some functional categories the trend in regulatory innovations appears to be correlated
with an increased or decreased appearance of the genes themselves. The proportion of new
genes that are associated with inter-cellular signaling closely mirrors the proportion of
regulatory innovations near genes with this function (Fig. 2). During the time from the
amniote ancestor to the placental mammalian ancestor there was an enrichment for both new
genes and new regulatory elements associated with inter-cellular signaling. However, for
transcription factors, which show the most dramatic change in their proportion of regulatory
innovations, the proportion of gene births has stayed relatively constant. This hints that the
selective pressures on novel regulatory elements and novel genes may be similar for some
classes of genes and different for others. It could be that evolutionary advances in some cell
functions may be realized both through novel genes and novel regulatory elements, while
advances in other cell functions may preferentially happen through one of the two methods.
As regulatory innovations near genes involved in post-translational protein modification
have become increasingly common in placental mammals, the new appearance of these
genes themselves has become increasingly rare. This emphasizes the fact that many new
regulatory innovations are associated with ancient genes. For example, we have identified
10 regulatory innovations near protein kinase D1 (PRKD1, PKD1) since the human lineage
split with cow. This is the most regulatory innovations of any post-translational protein
modification gene during this recent time period, yet PRKD1 dates to at least our tetrapod
ancestor. This enrichment for recent CNEEs near genes involved in post-translational
protein modification is consistent across humans, cows, and to a lesser degree mouse, even
when looking only at independent events after these species diverged (Tables S8 – S10).
Finally, to further validate this approach, we looked outside of the Gene Ontology at a
particularly well-studied gene set associated with the evolution of body hair, a phenotypic
trait characteristic of mammals. There is a long history of genetic studies concerning mouse
coat phenotypes that provides a set of almost 400 genes in the Mouse Genome Database for
this process (27). Hair development begins as an area of epidermal thickening (epidermal
placode) and shares the first developmental steps with avian feathers (28). The remaining
stages in hair development do not appear until the mammalian ancestor, when body hair first
originates. There is a slight enrichment for newly introduced regulatory regions to be
associated with hair genes during the time of our amniote ancestor, when the basal stages of
Lowe et al. Page 5













hair development originated (Fig. 3). Then the enrichment for putative novel regulatory
regions near hair-associated genes peaks in the mammalian ancestor, at the time body hair
first originates. We do not see a clear enrichment for new genes, only for new regulatory
elements.
It appears that at least three broad periods of regulatory innovation can be reliably detected
in several vertebrate lineages. The first period, ranging from our vertebrate ancestor until
about 300 Mya, when mammals split with birds and reptiles, is dominated by regulatory
innovations near transcription factors and the key developmental genes they control. The
second period, from about 300 Mya to 100 Mya, is characterized by a high frequency of
regulatory innovations near receptors of extra-cellular signals, and a gradual decline in
innovations near trans-dev genes. These two trends occurred independently in tetrapods and
ray-finned fish. Finally, at least in placental mammals, we see a third period in which
regulatory innovations for trans-dev and receptor genes have dropped to background
frequencies, while regulatory innovations for genes involved in post-translational protein
modification, including those in intra-cellular signaling pathways, are on the rise. Further
sequencing of additional vertebrate species will make it possible to determine the
pervasiveness of these trends and to look for additional functional categories that may be
associated with epochs of evolutionary change in particular lineages.
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Regulatory innovation. Each panel shows data for the frequency of regulatory innovations
near genes in a different GO category (panel title). Colors indicate the five lineages studied.
Each data point (colored circle) represents the relative frequency of regulatory innovations
on a specific lineage (color) as determined by analysis using the reference genome for that
lineage. The relative frequency (enrichment factor) for a specific GO category is defined as
the frequency of innovations in genes of this GO category as compared to what would be
expected by selecting genomic regions at random (denoted by the horizontal line at the
relative frequency of 1.0). Each data point is an estimate from at least 2800 putative
regulatory innovations. The time associated with each data point, indicated on the horizontal
axis, is the midpoint of the branch of the phylogenetic tree on which these innovations are
inferred to have occurred by comparative genome analysis (Fig. S3 and Tables S1 and S2).
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The horizontal axis is annotated with both geologic time periods as well as speciation events
for the lineages analyzed.
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A comparative history of innovations in regulatory regions and genes. Each panel shows
data for the frequency of regulatory innovations near genes in a different GO category
(panel title) as well as the frequency of genic innovations for that GO category. Each data
point for regulatory innovations (red circle) represents the percent of regulatory innovations
appearing on a branch in the human lineage that are associated with a gene annotated with
the given GO category. Each data point for protein-coding genes (red x) represents the
percent of protein-coding genes appearing on a branch that are associated with the given GO
category. The time associated with each data point is as described in Fig. 1.
Lowe et al. Page 10














Enrichment for regulatory regions originating near genes involved in hair development
during the time hair originated in evolution. For each branch we plot the percentage of genes
or regulatory elements created on that branch that are associated with hair development.
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